Loerop James bought ACRS
December 31, 2025 · Form 4 insider transaction
Loerop James bought 73,750 shares of Aclaris Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
73,750
Price
N/A
Total value
N/A
InsiderLoerop James
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 31, 2025
Filing dateJanuary 5, 2026
Shares owned after177,056
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.